A modified work-life balance (WLB) concept for older adults aged ≥ 55 years.
The FDA approved nirsevimab (Beyfortus) on Monday for preventing respiratory syncytial virus (RSV)-related lower respiratory tract infections in infants and very young children. Delivered as
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s